Cardiovascular Outcome of the SGLT2 Inhibitor in Acute Myocardial Infarction: A Meta-Analysis

Cardiovascular Outcome of the SGLT2 Inhibitor in Acute Myocardial Infarction: A Meta-Analysis

Background: Unexpected cardiovascular events are likely to occur within a short period following an acute myocardial infarction (AMI). The sodium-glucose co-transporter 2 inhibitor (SGLT2-I) is a recently recommended drug for the treatment of AMI. However, its role in the risk of...

Full description

Bibliographic Details
Main Authors: Siqi Hu, Ting Tang, Qingwen Yu, Xuhan Tong, Yao You, Shenghui Zhang, Chen Chen, Jiake Tang, Chunyi Wang, Hu Wang, Xinyan Fu, Juan Chen, Xingwei Zhang, Mingwei Wang, Ling Liu
Format: Article
Language:English
Published: IMR Press 2025-02-01
Series:Reviews in Cardiovascular Medicine
Subjects:
cardiovascular outcome
sglt2 inhibitor
acute myocardial infarction
meta-analysis
Online Access:https://www.imrpress.com/journal/RCM/26/2/10.31083/RCM26136

Internet

https://www.imrpress.com/journal/RCM/26/2/10.31083/RCM26136

Similar Items